At 4.6% CAGR, Lung Cancer Surgery Market Size Set to Register 8.0 Billion USD by 2027

Share This Article

According to the new market research report “Lung Cancer Surgery Market By Instrument ((Clamps, Foreceps, Trocars, Retractors, Scissors), Monitoring & Endoscopic Devices), Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy, Sleeve Resection), MIS) – Forecast to 2027”, published by Nova One Advisor , The global Lung Cancer Surgery market gathered revenue around USD 4.9 Billion in 2020 and market is set to grow USD 8.0 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 4.6% during the prediction period 2021 to 2027. 

Get your Customized Research Report@ https://www.novaoneadvisor.com/report/customization/4406

Growth Factors:

Market growth is largely driven by factors such as the technological advancements in lung cancer treatment, increasing incidence and prevalence of lung cancer, growing trend of smoking tobacco, rising geriatric population, increasing emphasis on early diagnosis & treatment of cancers, and availability of reimbursement. However, the high cost of lung cancer diagnosis & surgery is expected to restrain the growth of this market during the forecast period.

Market Dynamics
Driver: Increasing incidence of lung cancer
Cancer is the second-leading cause of death worldwide, accounting for 10 million deaths in 2020. Globally, about 1 in 6 deaths occur due to cancer (Source: World Health Organization). 19.3 million new cases were reported in 2020. The increase in cancer incidence at a global scale also indicates an increasing trend for the prevalence of lung cancers worldwide. In this scenario characterized by a favorable funding environment and effective treatment options, the growing incidence and prevalence of cancer are expected to increase the number of patients opting for lung cancer surgery in the coming years. This, in turn, is expected to drive the growth of the market in the coming years.

Restraint:
Lung cancer treatments are primarily divided into four broader categories; diagnosis/imaging, surgeries, pharmacological assistance, and indirect costs (like transportation, caregiver wages, lodging, secondary effects treatments, and lost wages/ incomes). These categories incur substantial spending from government/insurance providers and additional costs paid by the patient itself. The hefty costs for treating lung cancers have created a substantial burden on the governments globally and cancer patients. Considering these high costs, despite the presence of a large patient pool, a limited number of patients opt for surgical interventions to treat their condition. This is a major factor restraining market growth.

Challenges: 
To achieve better outcomes, lung cancer surgeries are performed by skilled professionals. These surgeries are considered to involve more risks when compared to other surgeries due to challenges such as air leaks, movement of tumors due to breathing, and accumulation of fluids in the chest during the procedure. Over the years, the incidence and prevalence of lung cancer have increased and are expected to increase further in the coming years. However, there has not been a subsequent growth in the number of oncologists; this situation is more pronounced in developing countries. The rise in demand is driven by factors like the aging and growth of the population and improvements in cancer survival rates; however, the slow/ lagged growth in the skilled labor is attributed to factors like the oncology workforce is aging and retiring in increasing numbers.

Download This Full Research Report, Click Here@ https://www.novaoneadvisor.com/report/checkout/4406

Recent report on the Lung Cancer Surgery market, with the help of a comprehensive outlook, provides readers with an assessment of the global market landscape. This study on the Lung Cancer Surgery market analyzes the scenario for the period of 2017 to 2027, wherein, 2021 is the base year and 2020 is historical data. This report enables readers to make important decisions with regard to their business, with the help of a wealth of Information enclosed in the study. The report also provides the compound annual growth rate (CAGR) of the global Lung Cancer Surgery market for the forecast period of 2021–2027. This data can help readers interpret quantitative growth aspects of the global market during the forecast period. It presents a wealth of information on key market dynamics, including drivers, market trends, and challenges, as well as the structure of the global market across the globe.

The report analyzes the historical and present-day scenario of the global Lung Cancer Surgery market to accurately gauge its growth potential. The study presents detailed information about important growth factors, restraints, and key trends that are creating the landscape for growth of the global market in order to identify opportunities for stakeholders.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the Lung Cancer Surgery market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the market.

The report delves into the competition landscape of the global Lung Cancer Surgery market. Key players operating in the market have been identified and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the Lung Cancer Surgery market that are profiled in this report.

Y-o-Y growth comparison, volume and revenue comparison, and market share comparison of various market segments are provided in the report. The Lung Cancer Surgery market is analyzed at both regional and country levels.

Lung Cancer Surgery Market top Key Players:

Significant Market Participants Operational in the Lung Cancer Surgery Market are:

Accuray Inc. (US), AngioDynamics Inc. (US), Ethicon US, LLC (US), Intuitive Surgical Inc. (US), Olympus Corporation (Japan), Teleflex Incorporated (US), Ackermann Instrumente GmbH (Germany), KARL STORZ GmbH (Germany), Scanlan International Inc. (US), TROKAMED GmbH (Germany), Medtronic Plc. (Ireland), Siemens Healthcare (Germany), Richard Wolf GmbH (Germany), Phoenix Surgical Holdings Limited (England), Key Surgical LLC (US), Surgical Holdings (England), FusionKraft (India), KLS Martin Group (Germany), Sontec Instruments Inc. (US), and Wexler Surgical Inc. (US).

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

By Surgical Devices

  • Surgical Instruments
    • Hand Instruments
      • Staplers
      • Foreceps
      • Retractors
      • Rib Shears
      • Trocar
      • Cutters
      • Clamps
      • Scissors
      • Elevators
      • Other Hand Instruments
      • Powered Surgical Equipment
  • Monitoring & Visaulising Systems
    • Cameras & Video Support
    • Endoscopic Trocars with Optical Views
  • Endosurgical Equipment

By Surgical Procedures

  • Thoracotomy
    • Lobectomy
    • Sleeve Resection
    • Segmentectomy
    • Pnuemenectomy
  • Minimally Invasive Surgeries

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

 Research Methodology

A unique research methodology has been utilized to conduct a comprehensive research on the growth of the global Lung Cancer Surgery market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions. Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.

These primary and secondary sources provided exclusive information during interviews, which serves as a validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global Lung Cancer Surgery market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimates the future prospects of the global market more reliable and accurate.

Key Questions are

  • What are the key factors influencing the Lung Cancer Surgery market in each region?
  • How much value will the global market generate by the end of the forecast period?
  • What will be the CAGR of the global market between 2021 and 2027?
  • What would be the Y-o-Y growth trend of the global market between 2021 and 2027?
  • What is the future scope and current trends in technologies of the global market?
  • What is the revenue of the global market based on segments?
  • Which key strategies are used by top players of the global market?
  • Which are the leading companies in the global market?
  • What are the essential strategies by key stakeholders in the market to expand their geographic presence?
  • What are the major advancements witnessed in the global market?

 Why Buy this Report?

The purpose of Nova one advisor’s Lung Cancer Surgery market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.

TABLE OF CONTENT

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Lung Cancer Surgery Market, By Surgical Devices

7.1.  Lung Cancer Surgery Market, By Surgical Devices, 2021-2027

7.1.1.     Accuray Inc. (US)

7.1.1.1.          Market Revenue and Forecast (2016-2027)

7.1.2.     Monitoring & Visaulising Systems

7.1.2.1.          Market Revenue and Forecast (2016-2027)

7.1.3.     Endosurgical Equipment

7.1.3.1.          Market Revenue and Forecast (2016-2027)

Chapter 8.    Global Lung Cancer Surgery Market, By Surgical Procedures

8.1.  Lung Cancer Surgery Market, By Surgical Procedures, 2021-2027

8.1.1.     Thoracotomy

8.1.1.1.          Market Revenue and Forecast (2016-2027)

8.1.2.     Minimally Invasive Surgeries

8.1.2.1.          Market Revenue and Forecast (2016-2027)

Chapter 9.    Global Lung Cancer Surgery Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.     Market Revenue and Forecast, By Surgical Devices (2016-2027)

9.1.2.     Market Revenue and Forecast, By Surgical Procedures (2016-2027)

9.1.3.     U.S.

9.1.3.1.          Market Revenue and Forecast, By Surgical Devices (2016-2027)

9.1.3.2.          Market Revenue and Forecast, By Surgical Procedures (2016-2027)

9.1.4.     Rest of North America

9.1.4.1.          Market Revenue and Forecast, By Surgical Devices (2016-2027)

9.1.4.2.          Market Revenue and Forecast, By Surgical Procedures (2016-2027)

9.2.  Europe

9.2.1.     Market Revenue and Forecast, By Surgical Devices (2016-2027)

9.2.2.     Market Revenue and Forecast, By Surgical Procedures (2016-2027)

9.2.3.     UK

9.2.3.1.          Market Revenue and Forecast, By Surgical Devices (2016-2027)

9.2.3.2.          Market Revenue and Forecast, By Surgical Procedures (2016-2027)

9.2.4.     Germany

9.2.4.1.          Market Revenue and Forecast, By Surgical Devices (2016-2027)

9.2.4.2.          Market Revenue and Forecast, By Surgical Procedures (2016-2027)

9.2.5.     France

9.2.5.1.          Market Revenue and Forecast, By Surgical Devices (2016-2027)

9.2.5.2.          Market Revenue and Forecast, By Surgical Procedures (2016-2027)

9.2.6.     Rest of Europe

9.2.6.1.          Market Revenue and Forecast, By Surgical Devices (2016-2027)

9.2.6.2.          Market Revenue and Forecast, By Surgical Procedures (2016-2027)

9.3.  APAC

9.3.1.     Market Revenue and Forecast, By Surgical Devices (2016-2027)

9.3.2.     Market Revenue and Forecast, By Surgical Procedures (2016-2027)

9.3.3.     India

9.3.3.1.          Market Revenue and Forecast, By Surgical Devices (2016-2027)

9.3.3.2.          Market Revenue and Forecast, By Surgical Procedures (2016-2027)

9.3.4.     China

9.3.4.1.          Market Revenue and Forecast, By Surgical Devices (2016-2027)

9.3.4.2.          Market Revenue and Forecast, By Surgical Procedures (2016-2027)

9.3.5.     Japan

9.3.5.1.          Market Revenue and Forecast, By Surgical Devices (2016-2027)

9.3.5.2.          Market Revenue and Forecast, By Surgical Procedures (2016-2027)

9.3.6.     Rest of APAC

9.3.6.1.          Market Revenue and Forecast, By Surgical Devices (2016-2027)

9.3.6.2.          Market Revenue and Forecast, By Surgical Procedures (2016-2027)

9.4.  MEA

9.4.1.     Market Revenue and Forecast, By Surgical Devices (2016-2027)

9.4.2.     Market Revenue and Forecast, By Surgical Procedures (2016-2027)

9.4.3.     GCC

9.4.3.1.          Market Revenue and Forecast, By Surgical Devices (2016-2027)

9.4.3.2.          Market Revenue and Forecast, By Surgical Procedures (2016-2027)

9.4.4.     North Africa

9.4.4.1.          Market Revenue and Forecast, By Surgical Devices (2016-2027)

9.4.4.2.          Market Revenue and Forecast, By Surgical Procedures (2016-2027)

9.4.5.     South Africa

9.4.5.1.          Market Revenue and Forecast, By Surgical Devices (2016-2027)

9.4.5.2.          Market Revenue and Forecast, By Surgical Procedures (2016-2027)

9.4.6.     Rest of MEA

9.4.6.1.          Market Revenue and Forecast, By Surgical Devices (2016-2027)

9.4.6.2.          Market Revenue and Forecast, By Surgical Procedures (2016-2027)

9.5.  Latin America

9.5.1.     Market Revenue and Forecast, By Surgical Devices (2016-2027)

9.5.2.     Market Revenue and Forecast, By Surgical Procedures (2016-2027)

9.5.3.     Brazil

9.5.3.1.          Market Revenue and Forecast, By Surgical Devices (2016-2027)

9.5.3.2.          Market Revenue and Forecast, By Surgical Procedures (2016-2027)

9.5.4.     Rest of LATAM

9.5.4.1.          Market Revenue and Forecast, By Surgical Devices (2016-2027)

9.5.4.2.          Market Revenue and Forecast, By Surgical Procedures (2016-2027)

Chapter 10.   Company Profiles

10.1.                 Accuray Inc. (US)

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.                 AngioDynamics Inc. (US)

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.                 Ethicon US, LLC (US)

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.                 Intuitive Surgical Inc. (US)

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.                 Olympus Corporation (Japan)

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.                 Teleflex Incorporated (US)

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.                 Ackermann Instrumente GmbH (Germany)

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.                 KARL STORZ GmbH (Germany)

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.                 Scanlan International Inc. (US)

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.              TROKAMED GmbH (Germany)

10.10.1.                   Company Overview

10.10.2.                   Product Offerings

10.10.3.                   Financial Performance

10.10.4.                   Recent Initiatives

10.11.              Medtronic Plc. (Ireland)

10.11.1.                   Company Overview

10.11.2.                   Product Offerings

10.11.3.                   Financial Performance

10.11.4.                   Recent Initiatives

10.12.              Siemens Healthcare (Germany)

10.12.1.                   Company Overview

10.12.2.                   Product Offerings

10.12.3.                   Financial Performance

10.12.4.                   Recent Initiatives

10.13.              Richard Wolf GmbH (Germany)

10.13.1.                   Company Overview

10.13.2.                   Product Offerings

10.13.3.                   Financial Performance

10.13.4.                   Recent Initiatives

10.14.              Phoenix Surgical Holdings Limited (England)

10.14.1.                   Company Overview

10.14.2.                   Product Offerings

10.14.3.                   Financial Performance

10.14.4.                   Recent Initiatives

10.15.              Phoenix Surgical Holdings Limited (England)

10.15.1.                   Company Overview

10.15.2.                   Product Offerings

10.15.3.                   Financial Performance

10.15.4.                   Recent Initiatives

10.16.              Surgical Holdings (England)

10.16.1.                   Company Overview

10.16.2.                   Product Offerings

10.16.3.                   Financial Performance

10.16.4.                   Recent Initiatives

10.17.              FusionKraft (India)

10.17.1.                   Company Overview

10.17.2.                   Product Offerings

10.17.3.                   Financial Performance

10.17.4.                   Recent Initiatives

10.18.              KLS Martin Group (Germany)

10.18.1.                   Company Overview

10.18.2.                   Product Offerings

10.18.3.                   Financial Performance

10.18.4.                   Recent Initiatives

10.19.              Sontec Instruments Inc. (US)

10.19.1.                   Company Overview

10.19.2.                   Product Offerings

10.19.3.                   Financial Performance

10.19.4.                   Recent Initiatives

10.20.              Wexler Surgical Inc. (US)

10.20.1.                   Company Overview

10.20.2.                   Product Offerings

10.20.3.                   Financial Performance

10.20.4.                   Recent Initiatives

Chapter 11.   Appendix

11.1.                 About Us

11.2.                 Glossary of Terms

You Can Purchase Complete Report@ https://www.novaoneadvisor.com/report/checkout/4406

About Us

Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@novaoneadvisor.com

Web: https://www.novaoneadvisor.com/

James Root

James Root have over 6+ years of experience working in business development, and customer retention. I’ve gained my experience through serving higher education, healthcare, automotive, aerospace, manufacturing, local government and hospitality businesses with technical solutions.

View all posts by James Root →